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Abstract: The effects of the initial emulsion structure (droplet size and emulsifier) on the properties
of β-carotene-loaded emulsions and the bioavailability of β-carotene after passing through simulated
gastrointestinal tract (GIT) digestion were investigated. Exposure to GIT significantly changed the
droplet size, surface charge and composition of all emulsions, and these changes were dependent on
their initial droplet size and the emulsifiers used. Whey protein isolate (WPI)-stabilized emulsion
showed the highest β-carotene bioaccessibility, while sodium caseinate (SCN)-stabilized emulsion
showed the highest cellular uptake of β-carotene. The bioavailability of emulsion-encapsulated
β-carotene based on the results of bioaccessibility and cellular uptake showed the same order with
the results of cellular uptake being SCN > TW80 > WPI. An inconsistency between the results of
bioaccessibility and bioavailability was observed, indicating that the cellular uptake assay is necessary
for a reliable evaluation of the bioavailability of emulsion-encapsulated compounds. The findings in
this study contribute to a better understanding of the correlation between emulsion structure and the
digestive fate of emulsion-encapsulated nutrients, which make it possible to achieve controlled or
potential targeted delivery of nutrients by designing the structure of emulsion-based carriers.
Keywords: emulsion; β-carotene; digestion; cellular uptake; bioavailability
1. Introduction
Carotenoids are a class of natural pigments abundant in plants and fruits that can have many
health benefits when consumed at proper levels. Previous studies have shown that carotenoids
possess strong antioxidant activity and that intake of carotenoid-rich foods was correlated with the
reduced risks of several chronic diseases, including cancers, cardiovascular diseases, age-related
macular degeneration and cataracts [1,2]. Several potential mechanisms have been proposed to explain
these biological activities, e.g., scavenging free radicals and preventing oxidative damage, altering
transcription activity or functioning as precursor of vitamin A [3]. β-carotene is a representative
member of the carotenoids family and has been widely studied due to its high pro-vitamin A activity.
However, extreme water insolubility and instability greatly limit the health benefits of β-carotene.
Therefore, the delivery of β-carotene requires an encapsulation and protection mechanism. Emulsions
are ideal carriers for lipophilic nutrients, such as β-carotene, due to their ease of operation, maintenance
of chemical stability, controlled release and potential for target delivery of encapsulated compounds [4].
Since emulsions are widely used as delivery systems for lipophilic nutrients [4,5], an in-depth
understanding of the biological fate of emulsion droplets and encapsulated compounds in the digestive
tract is necessary for optimizing the delivery efficiency of emulsions. The determination of the changes
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of droplet properties, e.g., size, surface charge and the subsequent release of encapsulated compounds
during digestion, can also contribute to a better understanding of the mechanism of improved
bioavailability by emulsion delivery. When being exposed to gastrointestinal tract (GIT) digestion,
emulsions can show great changes in their droplet size, surface charge or compositions [6,7], due to the
extremely acidic environment in the gastric phase or as a result of enzymatic hydrolysis in the mouth,
gastric and intestinal phases; all of these changes can influence the digestion of emulsion droplets and
thus the biological fate of nutrients within droplets.
Many previous studies have investigated the influence of emulsion structure, e.g., droplet size
or emulsifiers, on the digestibility of lipid droplets in emulsions [8], the physical and chemical
stability of emulsion-encapsulated nutrients [3] and the release of these encapsulated nutrients after
passing through simulated GIT digestion [9]. The bioaccessibility of these encapsulated nutrients in
emulsions with different initial droplet size [10], emulsifiers [11] and oil compositions [12] was also well
evaluated by measuring the content of nutrients in micelle fractions after GIT digestion. However, these
studies did not investigate the absorption of these nutrient-loaded micelles by enterocytes, which is
important for the evaluation of the bioavailability of encapsulated nutrients. This may also be the
main cause of the inconsistency observed between the bioaccessibility and the in vivo bioavailability
of emulsion-encapsulated nutrients [13]. In addition, Dairy proteins are widely used as food emulsion
stabilizers due to their edibility, health benefits and good amphiphilic properties. Many studies have
been done on dairy protein-stabilized emulsions. However, the information on the cellular uptake of
encapsulated nutrients in dairy-protein-stabilized emulsions (e.g., whey protein isolate or casein) after
passing through GIT was very limited. The comparison between different dairy proteins concerning
their influence on the digestion behavior of emulsions containing nutrients in GIT and the subsequent
enterocytes cell absorption of released nutrients after GIT still needs further investigation. Furthermore,
little is known about the influence of small initial droplet sizes (~1 µm) on the bioaccessibility of
encapsulated nutrients.
Therefore, this study was designed to investigate the bioaccessibility and cellular uptake of
an encapsulated lipophilic nutrient (β-carotene) in emulsions with different initial droplet sizes
(~1 µm) and emulsifiers (whey protein isolate, sodium caseinate and Tween 80) by the simulated GIT
digestion system and the Caco-2 cellular uptake assay. The changes of emulsion properties, such as
droplet size and surface charge, during GIT digestion were also tested.
2. Material and Methods
2.1. Materials
β-carotene (BC) (>93%, UV), sodium caseinate (SCN), Tween® 80 (Polysorbate 80, TW80),
pepsin (≥250 unit/mg), pancreatin (4× USP), bile salts, Dulbecco’s Modified Eagle’s Medium
(DMEM) (containing 4.5 g/L D-glucose), penicillin and streptomycin (100×), fetal bovine serum
(FBS), phosphate-buffered solution (PBS) and cell lysis buffer were purchased from Sigma-Aldrich
(St. Louis, MO, USA). Sunflower oil was purchased from a local supermarket, and whey protein isolate
(WPI) was obtained from Davisco Food International (Le Sueur, MN, USA). All other chemicals and
reagents used were of AR-grade and obtained from Sigma-Aldrich.
2.2. Emulsion Preparation
2.2.1. Preparation of BC-Loaded Emulsions with Different Droplet Sizes
A continuous phase was prepared by dissolving WPI (1.0%, w/w) in water containing 0.01%
(w/w) sodium azide (anti-bacterial agents). The oil phase was prepared by dissolving BC (0.2%, w/w)
in the sunflower oil (10%, w/w) at 140 ◦C for 15 s and then mixed with the continuous phase at
a speed of 10,000 rpm for 1 min using an Ultra-Turrax (IKA, Staufen, Germany) followed by further
homogenization (APV 1000, SPX Flow Technology, Charlotte, NC, USA) at 20 or 70 MPa.
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2.2.2. Preparation of BC-Loaded Emulsions with Different Emulsifiers
WPI, SCN or TW80 was dispersed (1.0%, w/w) in water containing 0.01% (w/w) sodium azide
as continuous phases. The subsequent emulsion preparation was performed using the same process
mentioned above with high-pressure homogenization at 70 MPa.
2.2.3. Characterization of Droplet Size and Surface Charge
The mean droplet size, and zeta potential of emulsions were determined by dynamic light
scattering (DLS) using a laser particle analyser (Nano-ZS, Malvern Instruments, Worcestershire, UK).
Emulsions were 1000-fold diluted before testing.
2.3. Rheological Analysis
Rheological properties of emulsions were determined using an AR 2000 ex rheometer
(TA Instruments, Crawley, UK)). A concentric cylinder geometry (stator inner radius = 15 mm,
rotor outer radius = 14 mm, gap = 5920 µm) were selected. A viscosity test was performed over
a shear rate range of 0–200 s−1 at 25 ◦C.
2.4. Creaming Stability
The creaming stability of different emulsions was evaluated using a Lumisizer (LUM GmbH,
Berlin, Germany) as described previously [14]. In this study, emulsions were centrifuged at 2300× g at
25 ◦C with a scanning rate of once every 10 s for 1200 s.
2.5. In Vitro Simulated GIT Digestion
An in vitro simulated GIT digestion method employed in a previous study [7] was used to digest
emulsions. The digesta after each phase (mouth, gastric and intestinal phase) were sampled for the
determination of droplet size and zeta potential. The simulated saliva fluid (SSF), gastric fluid (SGF)
and intestinal fluid (SIF) were prepared as described previously [7].
Mouth phase: Emulsions were mixed with SSF (1:1, v/v), and the pH was adjusted to 6.8 and
incubated at 37 ◦C for 10 min with continuous agitation at 100 rpm.
Gastric phase: The digesta from the mouth phase were mixed with the SGF (1:1, v/v), and the pH
of the mixture was adjusted to 2.5. The mixture was then incubated at 37 ◦C for 2 h with continuous
agitation at 100 rpm. The enzyme activity of pepsin in the final mixture was 2000 U/mL.
Small intestinal phase: The digesta sample from the gastric phase was mixed with the SIF (1:1, v/v).
The pH of the mixture was adjusted to 7.0, and it was incubated at 37 ◦C for 2 h with continuous agitation
at 100 rpm. The enzyme activity of pancreatin (based on trypsin) in the final mixture was 100 U/mL.
2.6. In Vitro Bioaccessibility of BC
The bioaccessibility of BC after the intestinal phase was evaluated as described previously with
minor modification. An aliquot of raw digesta from the intestinal phase was centrifuged at 2700× g
for 40 min at 4 ◦C, and the supernatant was collected and considered as the micelle fraction, in which
the bioactive compound is solubilized. Aliquots of 2 mL of the raw digesta or the micelle fraction were
extracted twice with ethanol/n-hexane. The top layer containing the solubilized BC was collected and
analysed by RP-HPLC as described below.
The bioaccessibility of encapsulated BC was calculated using the following equation:
Bioaccessibility (%) =
Cmicelle
Cinitial
× 100% (1)
where Cmicelle and Cinitial are the concentration of BC in the micelle fraction after intestinal phase
digestion and initial emulsion before GIT digestion, respectively.
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2.7. Cellular Uptake by Caco-2 Cells
Caco-2 cells were seeded in a 6-well plate at a density of 3.5 × 105 cells well−1, and cellular
uptake experiments were performed 5–7 days after seeding. Micelle fractions of different BC-loaded
emulsions after the intestinal phase were 20-fold diluted with complete medium. One millilitre of
diluted samples was added to each well in a 6-well plate, which was then incubated at 37 ◦C and 5%
CO2 for 4 h. Before collection, cells were washed three times with PBS buffer solution. Then, cells were
collected, lysed, extracted and analysed for BC content by RP-HPLC.
2.8. Extraction of BC
BC was extracted from the micelle fraction or raw digesta emulsion systems with
ethanol/n-hexane (1:2, v/v) two times. The hexane layers were combined and dried under a stream of
nitrogen gas and dissolved in 0.6 mL ethanol for HPLC analysis.
2.9. HPLC Analysis of BC
The concentration of BC was determined using an Agilent 1200 series system with a DAD UV-Vis
detector (Agilent, Santa Clara, CA, USA); the column was reversed phase C18 (4.6 × 250 mm, 5 µm,
300 Å, Phenomenex); the operation temperature was 30 ◦C; elution was performed with 90% ethanol
and 10% acetonitrile from 0 to 15 min; the flow rate was 1 mL/min; the detection wavelength was
450 nm; the injection volume was 20 µL. The peak area of BC on HPLC showed a good linear correlation
with the BC concentration in the range of 0.05~5 µg/mL (data not shown).
2.10. Statistical Analysis
All experiments were repeated at least three times. One-way analysis of variance (ANOVA) was
employed to compare means of data. A t-test was used to determine the differences between means,
and significant differences were determined at the 0.05 level (p < 0.05).
3. Results and Discussion
3.1. Characterization of Emulsions
Emulsions showed a reduced droplet size with increasing homogenization pressure (HP) used
during their preparation (Table 1), which was as observed in many previous studies [15], and no
significant difference in droplet size of emulsions stabilized by whey protein isolate (WPI), sodium
caseinate (SCN) and Tween® 80 (TW80), processed at similar homogenization pressures, was observed.
Droplets of WPI- and SCN-stabilized emulsions were negatively charged, which is mainly attributed to
the protein molecules being negatively charged at pH (7.0), which is higher than their isoelectric
point (pH 4.0–5.0). WPI-stabilized emulsions with different droplet sizes (produced at different
homogenization pressures) showed similar surface charges. Droplets of TW-stabilized emulsion were
also negatively charged, but showed a much lower zeta potential (−25 mV) than that of the emulsions
stabilized with proteins (around −53 mV).
All emulsions showed very low viscosity. The SCN emulsion showed the highest viscosity,
followed by WPI- and TW80-stabilized emulsions, respectively (Table 1). WPI emulsions with large or
small droplets did not significantly differ in viscosity. The viscosity of emulsions can be influenced by
the proportion of the oil phase and emulsifiers [16,17] and increases with increasing oil content, owing
to the increased interfacial tension with water [18].
The SCN-stabilized emulsion showed the best creaming stability (p < 0.01), followed by WPI- and
TW-stabilized emulsion, respectively (Figure 1). The WPI-stabilized emulsion with a small droplet
size showed better creaming resistance than that with a large droplet size (p < 0.01). These results
suggested that the creaming stability of emulsions is dependent on their initial droplet size and
interfacial composition.
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Table 1. Droplet size, zeta potential, polydispersity index (PdI), viscosity and creaming index of emulsions.
Emulsions Size(d nm)
Zeta Potential
(mV)
Polydispersity Index
(PdI)
Viscosity
(mPa·s) Creaming Index
WPI-L 472 ± 20 a −53.2 ± 1.7 a 0.24 ± 0.07 a 1.78 ± 0.02 b 0.327 ± 0.007 a
WPI-S 205 ± 4 b −52.7 ± 0.6 a 0.24 ± 0.03 a 1.76 ± 0.02 b 0.169 ± 0.003 c
SCN 223 ± 12 b −52.1 ± 0.7 a 0.18 ± 0.02 b 1.94 ± 0.02 a 0.111 ± 0.002 d
TW 227 ± 12 b −25.1 ± 0.5 b 0.22 ± 0.01 a 1.72 ± 0.02 b 0.193 ± 0.005 b
WPI-L and WPI-S indicate emulsions stabilized by whey protein isolate with large and small initial droplet sizes;
SCN and TW indicate emulsions stabilized by sodium caseinate and Tween® 80. Different superscript letters
indicate significant differences between values in a column (p < 0.05).
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Figure 1. Integral light transmission of different emulsions. WPI-L and WPI-S indicate emulsions
stabilized by whey protein isolate with large and small droplet sizes, respectively. SCN and TW
emulsions indicate emulsions stabilized with sodium caseinate and Tween® 80, respectively.
According to Stokes’ law, creaming velo ity (V) is related to the radius of the particle (R),
the viscosity (µ) and density of the particle (ρp) and the continuous phase (ρ f ). Emulsions with
smaller droplet sizes, higher viscosity or higher particle density are thus expected to show better
creaming stability. In this study, the SCN-stabilized emulsion showed higher viscosity and a narrower
size distribution (Figure 2), as well as a lower PdI (Table 1) than WPI and TW emulsions, which may
explain why the former emulsion showed the best creaming stability.
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Figure 2. Size distribution of emulsions with different emulsifiers. WPI-S indicates whey protein
isolate-stabilized emulsion with small droplet size; SCN indicates sodium caseinate-stabilized emulsion;
TW indicates Tween® 80-stabilized emulsion.
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3.2. Characterization of Emulsions after Being Exposed to GIT Digestion
Exposure to GIT digestion can result in great changes in the properties of emulsions, e.g., droplet
size and surface charge, which accordingly will influence the digestion and absorption of nutrients
incorporated into emulsions. Thus, the droplet size and surface charge of BC-loaded emulsions after
being exposed to GIT were investigated.
All emulsions showed only a slight increase in droplet size after exposure to simulated mouth
digestion (Table 2). This is mainly attributed to the absence of mucin from the SSF used in this study
because mucin is the main cause of the increase in droplet size during mouth-phase digestion [10].
Table 2. Particle size and surface charge of emulsions after being exposed to simulated GIT digestion.
Emulsion
Droplet Size (d nm) Zeta Potential (mV) Polydispersity Index (PdI)
Mouse Phase GastricPhase
Intestinal
Phase Mouse Phase
Gastric
Phase
Intestinal
Phase Mouse Phase
Gastric
Phase
Intestinal
Phase
WPI-S 224 ± 11 b 774 ± 16 b 148 ± 12 a −51.7 ± 0.6 a 17.6 ± 0.9 a −64.3 ± 7.0 a 0.20 ± 0.02 b 0.71 ± 0.03 b 0.38 ± 0.01 a
WPI-L 471 ± 11 a 1256 ± 242 a 153 ± 9 a −53.3 ± 1.6 a 11.1 ± 0.5 b 64.0 ± 0.4 a 0.31 ± 0.09 a 1.0 ± 0.00 a 0.32 ± 0.04 a
SCN 224 ± 13 b 747 ± 20 b 166 ± 8 a −55.1 ± 0.4 a 9.0 ± 0.5 b −60.5 ± 3.3 a 0.19 ± 0.00 b 0.70 ± 0.07 b 0.23 ± 0.00c
TW80 229 ± 6 b 233 ± 8c 157 ± 9 a −14.3 ± 0.7 b 0.51 ± 0.0c −62.1 ± 1.0 a 0.16 ± 0.04 b 0.19 ± 0.01c 0.29 ± 0.04 b
WPI-L and WPI-S indicate emulsions stabilized by whey protein isolate with large and small droplets, respectively;
SCN and TW indicate emulsions stabilized with sodium caseinate and Tween® 80, respectively. Different superscript
letters indicate significant differences between values in a column (p < 0.05).
After the gastric phase, a dramatic increase in average droplet size (Table 2) and size distribution
(Figure 3b) of all emulsions was observed, except for the TW80-stabilized emulsion. The WPI-stabilized
emulsion showed a larger average droplet size (774 nm) at this point than that of the SCN-stabilized
emulsion (747 nm). The WPI-stabilized emulsion with large initial droplets showed a larger droplet
size (1256 nm) than that with the small initial droplets (774 nm). The results suggested that the initial
emulsion structure, e.g., emulsifiers and droplet sizes, can greatly influence the properties after being
exposed to simulated gastric digestion. The dramatic increase in droplet size during this process is
potentially attributed to several factors, including the low pH, incubation at 37 ◦C, ionic strength and
the hydrolysis of interfacial proteins by pepsin. However, incubation at 37 ◦C for 2 h did not increase
the droplet size of WPI- and SCN-stabilized emulsions (data not shown), and the previous study also
confirmed that dairy protein-stabilized emulsions were stable at pH < 4.0 [19]. Mao et al. [20] found
that WPI-stabilized multilayer emulsion droplets aggregated significantly in a NaCI solution of strength
≥150 mM because the relatively high ion strength can potentially reduce the electrostatic repulsion
between droplets [21] and lead to their aggregation. Furthermore, pepsin in SGF can hydrolyse WPI
and SCN at the oil-water interface and result in partially break-down of the interfacial layer structure
and, thus, the aggregation of oil droplets. These findings suggest that the increased droplet size of
emulsions during the gastric phase digestion may be mainly induced by the ionic strength (177 mM)
in SGF and the hydrolysis of proteins at the interface by pepsin.
Compared with the gastric phase, the droplet size of all emulsions dramatically decreased after
the intestinal phase (Table 2). The WPI-stabilized emulsion showed the smallest average droplet size
of 148 nm after intestinal phase digestion, followed by TW- (157 nm) and SCN-stabilized (166 nm)
emulsions, respectively. No significant difference between the WPI-stabilized emulsion with small
and large initial droplet sizes was observed. The decrease in droplet size was mainly attributed to
the rapid break-down of droplets due to the hydrolysis of proteins (WPI and SCN) and Tween 80
by trypsin and lipase, respectively, and the subsequent formation of small micelles stabilized by bile
salts (Figure 3c,d).
All emulsions were negatively charged after mouth phase digestion, which is mainly attributed
to the protein emulsifiers (WPI and SCN) being negatively charged at pH 6.8, which is above their
isoelectric point (pI). The SCN-stabilized emulsion had the highest surface charge, of −55.1 mV,
followed by the WPI- and TW-stabilized emulsions, at−51.7 mV−24.3 mV, respectively. No significant
Nanomaterials 2017, 7, 282 7 of 11
difference in surface charge between WPI-stabilized emulsions with small (−51.7 mV) and large
(−53.3 mV) droplet sizes was observed (Table 2).
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Figure 3. Size distribution of emulsions after passing through simulated GIT digestion. (a) Mouth phase;
(b) Gastric phase; (c) Intestinal phase; (d) Micelle fractions. WPI-S and WPI-L indicate whey protein
isolate-stabilized emulsions with small and large droplet sizes, respectively; SCN indicates sodium
caseinate-stabilized emulsion; TW indicates Tween® 80-stabilized emulsion.
WPI- and SCN-stabilized emulsions were positively charged after the gastric phase (Table 2), as
expected because pH 2.5 is below their pI. The WPI-stabilized emulsion had a higher surface charge
than the SCN emulsion (9.0 mV) after the gastric phase, and the WPI-stabilized emulsion with small
initial droplets showed a higher surface charge (17.6 mV) than the emulsion with a large initial droplet
size (11.1 mV). The TW-stabilized emulsion was almost neutrally charged after the gastric phase.
After the intestinal phase, all emulsions were negatively charged, and there was no significant
difference in charge between different emulsions. This is mainly attributed to the enzymatic hydrolysis
of proteins (WPI and SCN) and TW at the droplet surface by trypsin and lipase and the subsequent
absorption of other anionic molecules, e.g., bile salts, to the droplet/micelle surface, resulting in
a uniformly negatively-charged surface [10].
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3.3. In Vitro Bioaccessibility of BC
Effects of droplet size and the selection of emulsifiers on the in vitro bioaccessibility of
emulsion-encapsulated BC were investigated, as emulsion structure and interfacial composition
can significantly influence the bioaccessibility of nutrients incorporated into emulsions [10,12].
The WPI-stabilized emulsion (WPI-S) showed the highest (p < 0.05) bioaccessibility of 58.5%,
followed by the SCN- and TW-stabilized emulsions of 56.5% and of 41.3%, respectively (Figure 4a).
No significant difference between WPI-stabilized emulsions with small (WPI-S) and large initial
droplet sizes (WPI-L) was observed. This may be mainly attributed to the initial droplet size in this
study (d < 0.4 µm) being not as large as in previous studies [10,22], in which significant differences
in the bioaccessibility of emulsion-encapsulated nutrients in large and small droplets were observed.
However, when the initial droplet size was below 1 µm, this difference becomes less significant.
1 
 
 
(a) 
(b)
 
Figure 4. (a) Bioaccessibility and cellular uptake of encapsulated β-carotene; (b) Bioavailability of
encapsulated β-carotene based on the results of bioaccessibility and cellular uptake. WPI-S and WPI-L
indicate whey protein isolate-stabilized emulsions with small and large droplet sizes, respectively;
SCN indicates sodium caseinate-stabilized emulsion; TW indicates Tween® 80-stabilized emulsion.
Generally, the bioaccessibility of emulsion-encapsulated nutrients is closely related to the structure
of the emulsion, including initial droplet size, emulsifiers or oil phase compositions and proportions.
TW can be hydrolysed by lipase [23] in intestinal phase digestion and can act as a competitive substrate
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with lipid inside the oil droplets, which accordingly may decrease the hydrolysis rate of oil and thus
potentially decrease the release of encapsulated BC. This may explain why the TW-stabilized emulsion
showed a lower bioaccessibility than those stabilized with WPI and SCN.
3.4. Cellular Uptake of BC
In order to further evaluate the bioavailability of emulsion-encapsulated BC, to understand why
there is an inconsistency between the results of bioaccessibility by measuring the content of nutrients
in micelle fractions after GIT and in vivo bioavailability, a Caco-2 cell culture assay was employed to
investigate the cellular uptake of BC after GIT.
The SCN-stabilized emulsion showed a significantly higher (p < 0.05) cellular uptake of BC
(0.180 µg/mg protein) than TW80- (0.146 µg/mg protein) and WPI-stabilized (0.130 µg/mg protein)
emulsions (WPI-S) (Figure 4a), which is obviously different with the results of bioaccessibility described
above. This may explain why an inconsistency between the results of in vitro bioaccessibility and
in vivo bioavailability was observed. Generally, increased cellular uptakes of nanoparticles are mainly
attributed to their reduced particle size and different surface structures. However, the micelle fraction of
SCN-stabilized emulsion showed even a larger average droplet size than that of WPI- and TW-stabilized
emulsions and the surface charge of all of the micelles was not significantly different (p > 0.1) (Table 3),
indicating that increased cellular uptake of encapsulated BC in the SCN-stabilized emulsion could not
be attributed to the droplet size and surface charge.
Table 3. Particle size and zeta potential (ZP) of micelle fractions from different emulsions and the
in vitro bioavailability and cellular uptake of encapsulated β-carotene after passing through GIT
(mean ± STD, n = 2).
Micelles Size (d nm) ZP (mV)
WPI-L 158 ± 3 a −65.0 ± 0.5 a
WPI-S 142 ± 6 b −64.2 ± 0.7 a
SCN 160 ± 10 a −61.1 ± 3.3 a
TW 156 ± 7 a −63.0 ± 1.0 a
WPI-L and WPI-S indicate micelles from emulsions stabilized by whey protein isolate with large and small droplet
sizes after GIT, respectively; SCN and TW indicate micelles from sodium caseinate- and Tween® 80-stabilized
emulsions after GIT, respectively. Different superscript letters indicate significant difference between values in
a column (p < 0.05).
As is known, casein shows better surface activity than whey proteins (α-lactalbumin
and β-lactoglobulin) [24], which is mainly attributed to their different amino acid sequences.
After hydrolysis by pepsin and trypsin, SCN may produce more peptides that have amphiphilic
structures than WPI, and these peptides can bind to the surface of newly-formed BC-loaded micelles,
facilitating the interaction of micelles with Caco-2 cells and, thus, increasing the cellular uptake of
BC. This may explain why SCN-stabilized emulsion showed a higher cellular uptake of BC than
WPI-stabilized emulsion in this study.
No significant difference between WPI- and TW-stabilized emulsions was observed. Although
WPI-stabilized emulsions with different initial droplet sizes showed significantly different micelle sizes
after intestinal phase digestion, also no significant difference in cellular uptake of BC was observed
between them.
Based on the results of in vitro bioaccessibility and cellular uptake, the bioavailability of BC in
this study can be calculated according to the following equation [25]:
Bioavailability (%) = FC × FB × FA× FM
where FC is the fraction of BC before passing through GIT; FB is the bioaccessibility, which is the
fraction of BC in micelles after intestinal phase digestion in this study; FA is the absorption, which is
the cellular uptake fraction of BC in this study; FM is the metabolism, which is the fraction of BC in
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a bioactive form after the metabolism within GIT, epithelium cells, blood circulation system or liver.
This study did not refer to the test of metabolism within blood circulation and liver. Hence, FM was
not used in the calculation of the bioavailability.
As is shown in Figure 4b, the results of the bioavailability of different emulsions showed the
same variation tendency with the results of cellular uptake (Figure 4a). No significant difference
in bioavailability of BC between WPI-stabilized emulsions with large and small droplet sizes was
observed. SCN-stabilized emulsion showed the highest of 7.2%, followed by TW80- and WPI-stabilized
emulsions of 5.8% and 5.2%, respectively, which showed the same order as the results of cellular uptake
of BC (Figure 4b), indicating that increased bioavailability of these emulsion-encapsulated nutrients
may be mainly attributed to their increased cellular uptake of nutrient-loaded micelles after passing
through GIT. The cellular uptake assay is accordingly considered as a necessary assay for a better
evaluation of the in vitro bioavailability of encapsulated nutrients.
4. Conclusions
The choice of emulsifier, between whey protein isolate (WPI), sodium caseinate (SCN) and
Tween 80 (TW), significantly influenced the creaming stability, surface charge and viscosity of
β-carotene-loaded emulsions. The SCN-stabilized emulsion showed the highest creaming stability
and viscosity in all emulsions. Passing emulsions through simulated GIT led to great changes
in their droplet size, surface charge and compositions, and these changes were dependent on
initial droplet sizes and interfacial compositions. However, in vitro bioaccessibility and cellular
uptake of encapsulated β-carotene after GIT were mainly dependent on the interfacial compositions
(emulsifiers). The SCN-stabilized emulsion showed the highest cellular uptake of β-carotene, followed
by TW80- and WPI-stabilized emulsions, respectively, which showed the same order as the results
of the bioavailability of β-carotene, potentially indicating that the increased bioavailability of
emulsion-encapsulated β-carotene is mainly attributed to their increased cellular uptake. In addition,
an inconsistency between the results of the in vitro bioaccessibility and bioavailability of β-carotene
was observed, which may be the main cause of the reported inconsistency between the results of the
in vitro bioaccessibility and in vivo bioavailability of emulsion-encapsulated nutrients, suggesting that
the cellular uptake assay is necessary for a reliable evaluation of the in vitro bioavailability and may
be useful for predicting the in vivo bioavailability of emulsion-encapsulated compounds.
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